Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
A new form of electric transport in the bike industry with the use of an affordable and simple conversion kit. Swytch have developed a kinetically rechargeable add-on for existing bikes to convert them into eBikes for a range of up to 50 miles. Funding will result in additional units being manufactured and sold at a 70% margin. The products are available online and currently via 20 independent bike dealers, with over 100 more waiting on stock.
days to go:
Expired
investment:
£349,356
Arc's aim is to become the market leader in electrical recreational vehicles by using licensed battery automotive technology as the base. The company was born out of Jaguar Land Rover’s White Space. Since its pre-launch, the ‘Vector’ has attracted global interest with over 590 news articles covering its release across 55 countries. Arc also witnessed over 130 sales inquiries in relation to the limited 399 units which it is planning to produce. The company is on a mission of creating vehicles that challenge the environment while protecting it.
days to go:
Expired
investment:
£1,067,420
Go Zero is an electric taxi service. Since its inception in 2017, the company has completed over 10,000 journeys, saved an estimated 174 tonnes of CO2, and witnessed £530,000 worth of sales. The UK taxi industry is a £9 billion-pound industry and Go Zero, with its fleet of electric taxis powered by 100% renewable energy sources, aims to be a major disruptor. The company has received 100+ 5-star customer reviews and in 2019, it added 1600 new customers to its network. In February 2020, it launched the Go Zero Network, a network of 1,000 electric taxi franchises across the UK to expand electric travel for all. Being a part of the Go Zero Network offers a franchisee the opportunity to purchase a 5-year licence enabling them to operate their own business under the Go Zero brand. It also gives them the potential to earn between £30,000 and £50,000 after costs, based on performance metrics. With the investment, the company aims to recruit a high performing team to deliver market share, focused on sales, digital marketing, social media, franchise recruitment and management.
days to go:
Expired
investment:
£124,530
SpaceX is an aerospace manufacturer and space transportation services company founded in 2002 by Elon Musk that aims to reduce space transportation costs and eventually enable the colonisation of Mars. The company has developed several launch vehicles, rocket engines and Autonomous Spaceport Drone Ship (ASDS) landing platforms. Its project, Falcon 9, became the first rocket to accomplish a propulsive vertical landing in December 2015. As of March 2018, SpaceX had over 100 launches on its manifest representing about $12 billion (£9.24 billion) in contract revenue. The company has also ventured into providing satellite internet access by launching its Starlink project. As of 13th June 2020, it has launched 540 Starlink satellites. It will soon launch its Interplanetary Transport System (ITS), Starship, to further inter-planetary travel and colonisation. They will use the investment to grow its projects across various verticals.
days to go:
Expired
investment:
£8,752,000
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap.
days to go:
Expired
investment:
£199,227
